Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/pm/pnac165 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review.
Front Psychiatry
November 2024
Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti, Italy.
Article Synopsis
- - Methylphenidate (MPH), often used to treat ADHD, is increasingly misused by individuals with co-occurring psychiatric and substance use disorders, raising concerns about dependence and adverse effects.
- - A systematic review conducted in 2024 analyzed 12 studies, focusing on patterns of MPH misuse among patients with various psychiatric disorders, including conduct, mood, and anxiety disorders.
- - The results showed a significant correlation between MPH misuse and individuals with psychiatric disorders, particularly those also suffering from Alcohol Use Disorder, highlighting the need for targeted interventions and monitoring.
The Pharming of Cannabis: Have We Not Learned the Lesson from the Overuse of Opioids?
Pain Med
July 2023
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cannabidiol improves Nile tilapia cichlid fish welfare.
Sci Rep
October 2022
Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, São Paulo State University (UNESP), Botucatu, SP, 18618-689, Brazil.
Cannabidiol (CBD) is a substance derived from Cannabis sativa, widely studied in medicine for controlling neural diseases in humans. Besides the positive effects on humans, it also presents anxiolytic proprieties and decreases aggressiveness and stress in mammals. Therefore, CBD has the potential to increase welfare in reared animals, as it seems to reduce negative states commonly experienced in artificial environments.
View Article and Find Full Text PDFImpact of cannabis knowledge and attitudes on real-world practice.
Ann Allergy Asthma Immunol
October 2022
Canna Research Foundation, Boulder, Colorado; Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
Background: Increased cannabis consumption worldwide challenges allergists because of an upsurge in cannabis allergy and need to discuss cannabis with patients.
Objective: To determine the knowledge, attitudes, and practices regarding cannabis among allergists and their approach to recognizing and diagnosing suspected cannabis allergy.
Methods: The International Allergist Canna Knowledge, Attitudes, and Practices Survey was completed by members from 3 International Allergy Societies.
Cannabis-related allergies: An international overview and consensus recommendations.
Allergy
July 2022
Faculty of Medicine and Health Sciences, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Article Synopsis
- * It can cause allergic reactions, and different countries recognize various allergies related to cannabis.
- * Because cannabis is illegal in many places, studying it is tough, making it hard to diagnose allergies and find treatments.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!